Hospital Universitario Doctor Peset -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 34, Núm. 4, pp. e13942